Outlook Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
OTLK on Nasdaq
Location
111 S. Wood Avenue, Unit #100, Iselin, NJ

There are no Buy or Sell transactions made by insiders since 10/5/2024

Outlook Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Arun Pillai Director, 10%+ Owner $26.1M Feb 1, 2022
Tenshi Healthcare Pte. Ltd. 10%+ Owner $26.1M Apr 21, 2022
Ghiath M. Sukhtian Director, 10%+ Owner $19M May 27, 2025
Terry Dagnon Chief Operations Officer $741K Apr 20, 2023
Syntone Ventures LLC 10%+ Owner $716K Apr 15, 2024
Jeff Evanson Chief Commercial Officer $340K Mar 20, 2024
Lawrence Kenyon Chief Financial Officer, Director $33.8K Sep 26, 2024
Julian S. Gangolli Director Oct 1, 2025
Randy H. Thurman Director Oct 1, 2025
C. Russell Trenary III CEO AND PRESIDENT, Director Mar 20, 2024
Robert Jahr Chief Executive Officer Jul 1, 2025
Julia A. Haller Director Oct 1, 2025
Gerd Auffarth Director Oct 1, 2025
Faisal Ghiath Sukhtian Director Oct 1, 2025
Yezan Munther Haddadin Director Oct 1, 2025
Andong Huang Director Oct 1, 2025
Kurt J. Hilzinger Director Oct 1, 2025

Recent Insider Transactions by Companies or Individuals for Outlook Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.